Heart Disease Test Goes Global: India First Expansion

Cardio Diagnostics has initiated its first international expansion by partnering with Aimil and Dr Lal PathLabs to introduce its PrecisionCHD coronary heart disease test in India. This collaboration aims to address the significant challenge of cardiovascular disease in India, where CHD prevalence is notably high in both rural and urban populations. The innovative clinical blood test leverages a combination of epigenetic and genetic science with artificial intelligence to identify CHD at its molecular origins, providing physicians with crucial insights for patient management and personalized treatment strategies.

This advanced diagnostic tool offers a distinct advantage over traditional methods by being capable of detecting non-obstructive forms of CHD, such as myocardial infarction with no obstructive coronary arteries (MINOCA) and ischemia with no obstructive coronary arteries (INOCA). Clinical data supporting PrecisionCHD's efficacy in identifying these conditions was recently presented at a major American Heart Association event. The initial phase of the partnership will focus on integrating the test seamlessly within Dr Lal PathLabs' widespread network of laboratories and pathology services across India, ensuring full compliance with local regulatory standards.